However, anti-obesity medications are prescribed to only about 4% of eligible people due to concerns about safety or effectiveness, lack of health care provider training in weight management, excessive costs due to insurance companies refusing coverage, and a toxic stigma that portrays obesity as a lack of willpower
For example, CVS states that its PA logic requires patients to have the FDA-specified diagnosis, BMI thresholds, and to have tried diet/exercise interventions ( [42] )
That said, the 1mg dose of semaglutide is what has shown effectiveness in most studies, so it should suffice for most patients
Moreover, phosphorylation of mTOR at S2448 was enhanced by Exendin-4, confirming that GLP-1R signalling increases the activation state of mTOR, as previously demonstrated 16, 29, 30
Multiple sclerosis
doi: 10.1038/nature12656 21